Back

Melanocortin 1 receptor deficiency protects against pathological cardiac hypertrophy

25 August 2023 (11:15 - 12:00)
Organised by: Logo
Congress Presentation Part of: Myocardial remodelling (1) Cardiac Hypertrophy ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

About the speaker

Photo
Miss Anni Suominen

University of Turku, Turku (Finland)

7 More presentations in this session

Presentation thumbnail
  A high-throughput screening strategy identifies adenosine 5'-monophosphate as a novel enhancing molecule of the cardio-protective enzyme 5-oxoprolinase (OPLAH).
Mr J. Esquivel Gaytan (Groningen, NL)
Abstract Slides Video
Presentation thumbnail
Betaine therapy of cardiac hypertrophy through inhibition of Hydroxy-carboxylic Acid Receptor 1 signaling
Miss L. Yao (Nantong, CN)
Abstract Slides Video
Presentation thumbnail
ERBB4 stimulation mitigates atrial fibrillation and remodeling in a porcine DOCA model
Doctor M. Tubeeckx (Antwerp, BE)
Abstract Slides Video
Presentation thumbnail
The anti-fibrotic effect of atrial natriuretic peptide depends on myocardial accumulation of the peptide in rat heart
Professor S. Hatem (Paris, FR)
Abstract Slides Video
Presentation thumbnail
Rimeporide, a first in class Na/H exchanger-1 inhibitor, ameliorates right ventricular dysfunction and pulmonary arterial hypertension in a SuHx model
Doctor G. Milano (Lausanne, CH)
Abstract Slides Video

Access the full session

Session thumbnail
Myocardial remodelling (1)

The Event

Event poster

ESC Congress 2023

25 August 2023 11:15 CET
You may be interested in
thumbnail
Congress Session
Basic and Translational Late-Breaking Science session
thumbnail
Congress Session
Young Investigator Award Session in Basic and Translational Sciences
thumbnail
Congress Presentation
The role of IL15 in angiotensin II-mediated cardiac remodelling

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources